Stocks – Dax drags to new record – economy

Of the Dax remained on record course even at the end of the week. However, it only went up in mini-steps. At its peak, the leading German index climbed by 0.2 percent on Friday to 16,123 points. “The German share index shines these days more through stability and less through dynamism”, stated Jürgen Molnar, capital market strategist at the broker RoboMarkets. “Good quarterly figures still compensate for the worries about political measures to contain the fourth corona wave and support the market.” With the federal-state meeting in the coming week, however, the fear of new restrictions should also become an issue on the stock exchange, the expert fears.

Among the individual stocks in the Dax, investors, especially at Deutsche Telekom, took courageously. The group raised its outlook for 2021 again thanks to good business on both sides of the Atlantic. The shares climbed two percent. Delivery Hero shares were the biggest DAX winner with a premium of 4.6 percent. The reactions of the experts to the quarterly figures of the delivery service from the previous day were positive. In the M-Dax, Knorr Bremse was down four percent. The commercial vehicle and train supplier was unable to convince investors with its figures. For the year as a whole, the company forecast sales of EUR 6.6 billion to EUR 6.8 billion and somewhat narrowed its previous range of EUR 6.5 to 6.9 billion.

Salzgitter shares did not have a good day, which after the publication of their final quarterly figures were among the biggest losers in the S-Dax with a discount of almost five percent. According to stockbrokers, some investors had hoped for an increase in the forecast. However, the company only confirmed its outlook for the full year.

The US stock exchanges took a conciliatory course at the end of a turbulent week. Of the Dow Jones rose by 0.5 percent. Johnson & Johnson shares were up 1.2 percent. The pharmaceutical company wants to split into two companies. Some will specialize in consumer products. The pharmaceuticals and medical equipment businesses will remain with Johnson & Johnson.

.
source site